ncDR

LncRNA	Compound	Cancer	P-value	Effect
ENSG00000260973.1	ABT-263 (navitoclax)	Ovarian serous cyStomach adenocarcinomaenocarcinoma	0.041326734	Resistant
ENSG00000260973.1	ABT-263 (navitoclax)	Brain lower grade glioma	0.029308115	Sensitive